Washington Trust Advisors’s Maravai LifeSciences MRVI Stock Holding History

Washington Trust Advisors’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-201	Closed	-$2.01K	–	688
2023 Q3	$2.01K	Buy	201 +32	+19%	+$351	﹤0.01%	642
2023 Q2	$2.1K	Hold	169	–	–	﹤0.01%	624
2023 Q1	$2.37K	Hold	169	–	–	﹤0.01%	711
2022 Q4	$2.42K	Buy	169 +12	+8%	+$189	﹤0.01%	711
2022 Q3	$4K	Hold	157	–	–	﹤0.01%	758
2022 Q2	$4K	Buy	157 +32	+26%	+$1.01K	﹤0.01%	789
2022 Q1	$4K	Sell	125 -26	-17%	-$872	﹤0.01%	860
2021 Q4	$6K	Buy	+151	New	+$6.12K	﹤0.01%	824

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Washington Trust Advisors's MRVI Position: Q4 2023 in Review

Washington Trust Advisors sold out of Maravai LifeSciences (MRVI) in Q4 2023, closing a stake of 201 shares — an estimated $2.01K sold.

Washington Trust Advisors first reported a position in MRVI in Q4 2021 and held it in 8 quarters. The position peaked at $6K in Q4 2021. 223 funds tracked by Wall St. Rank hold MRVI as of Q4 2023.

Washington Trust Advisors reported no remaining Maravai LifeSciences position as of Q4 2023 after selling out during the quarter.
Washington Trust Advisors sold 201 Maravai LifeSciences shares in Q4 2023, an estimated $2.01K.
Washington Trust Advisors first reported a position in Maravai LifeSciences in Q4 2021 and held it in 8 quarters.
Washington Trust Advisors's Maravai LifeSciences position peaked at $6K in Q4 2021.
223 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q4 2023.

Based on Washington Trust Advisors's 13F filing for Q4 2023, filed 18 Jan 2024.